<!doctype html>

<head>
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="utf-8">
    <!-- CSS and JS imports -->
    <link rel="stylesheet" href="../static/local-overrides.css">
    <!-- Bootstrap v4alpha Imports -->
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0-alpha.6/css/bootstrap.min.css" integrity="sha384-rwoIResjU2yc3z8GV/NPeZWAv56rSmLldC3R/AZzGRnGxQQKnKkoFVhFQhNUwEyJ" crossorigin="anonymous">

    <style media="screen">
        body {
            padding-top: 70px;
            padding-bottom: 70px;
        }
    </style>

    <!-- Syntax Highlighter. Choose between get_pygments... or hljs. -->
    <!-- <link rel="stylesheet" href="../../../../../static/pygments.css"> -->
    <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/default.min.css">
    <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js"></script>
    <script>hljs.initHighlightingOnLoad();</script>

    <!-- Google Analytics -->
    <script>
        (function(i, s, o, g, r, a, m) {
            i['GoogleAnalyticsObject'] = r;
            i[r] = i[r] || function() {
                (i[r].q = i[r].q || []).push(arguments)
            }, i[r].l = 1 * new Date();
            a = s.createElement(o),
                m = s.getElementsByTagName(o)[0];
            a.async = 1;
            a.src = g;
            m.parentNode.insertBefore(a, m)
        })(window, document, 'script', 'https://www.google-analytics.com/analytics.js', 'ga');

        ga('create', 'UA-12498603-2', 'auto');
        ga('send', 'pageview');
    </script>

    <!-- ClustrMaps Tracking -->
    <!-- <script type="text/javascript" id="clstr_globe" src="//cdn.clustrmaps.com/globe.js?d=nhKoDpoTjWz4pC6CwI-fSy4hPoJ1uXwTLCfMCT3OK_8"></script> -->

    <!-- FontAwesome embed -->
    <script src="https://use.fontawesome.com/cb9dbe8e41.js"></script>
</head>

<title>BAARN 2016 Bullet Point Notes - Eric J. Ma's Personal Site</title>
<body class="body">
    <nav class="navbar navbar-toggleable navbar-light bg-faded fixed-top">
        <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#local-links" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
        </button>
        <div class="collapse navbar-collapse" id="local-links">
            <ul class="navbar-nav mr-auto">
                
                <li class="nav-item">
                    <a class="nav-link" href="/"><i class="fa fa-home" aria-hidden="true"></i> Home</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/resume"><i class="fa fa-file-text" aria-hidden="true"></i> Resume</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/blog"><i class="fa fa-rss" aria-hidden="true"></i> Blog</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/open-source"><i class="fa fa-code" aria-hidden="true"></i> Open Source</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/projects"><i class="fa fa-briefcase" aria-hidden="true"></i> Projects</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/talks"><i class="fa fa-microphone" aria-hidden="true"></i> Talks</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="/teaching"><i class="fa fa-university" aria-hidden="true"></i> Teaching</a>
                </li>
                
            </ul>
        </div>
    </nav>
    <div class="container">
        
  
  <!-- <div class="blog-post"> -->
  <link rel="stylesheet" href="../../../../../static/pygments.css">
  <div>
  
    <h2>BAARN 2016 Bullet Point Notes</h2>
  
  <p class="meta">
    written by
    
      <a href="https://twitter.com/ericmjl">Eric J. Ma</a>
    
    on 2016-06-16
  </p>
  <p>I attended the 2016 Boston Area Antibiotic Resistance Network meeting, held at the American Association for the Advancement of Science (AAAS). Here’s my bullet-point notes version of what went on.</p>
<p><strong>Session 1: New antibiotic strategies and therapeutics:</strong></p>
<p>In this section, scientists and group leaders presented novel ways of thinking about anti-bacterial treatment.</p>
<ol>
<li>Small molecules: focus on how to get molecules into the cell. (Anita Miller, Entasis)</li>
<li>Phage lysins: one component of phages, add externally to a bacteria. (Vincent Fischetti, Rockefeller University)</li>
<li>Ecobiotics: Consortia of commensal bacteria to restore general diversity, or impact specific pathways. (Matthew Henn, Seres Therapeutics)</li>
<li>Chemical discovery: Gene clusters can predict biochemical activity of natural products, great for discovering new chemicals. Cool point I took home - a gene cluster that encodes a molecule that destroys function of a common protein may also encode a resistant version of that version. (Emily Balskus, Harvard University)</li>
</ol>
<p><strong>Session 2: Creating a sustainable ecosystem for antibiotic production.</strong></p>
<p>In this section, representatives from finance, manufacturing, regulatory, and public policy discussed how they thought a sustainable ecosystem for producing antibiotics could be fostered.</p>
<p>Panel members:</p>
<ul>
<li>Joseph Larsen, BARDA</li>
<li>Cara Cassino, Contrafect</li>
<li>Edward Cox, FDA</li>
<li>Alan Carr, Needham & Co.</li>
</ul>
<p>Are there enough ideas in the pipeline?</p>
<ul>
<li>BARDA model: product accelerator; public-private partnerships.</li>
<li>Missing: a “pull” incentive - if I develop X successfully, I will get paid Y. Need lawmakers’ help.</li>
</ul>
<p>Are there enough ideas in the pipeline? </p>
<ul>
<li>BARDA model: product accelerator; public-private partnerships.</li>
<li>Missing: a “pull” incentive - if I develop X successfully, I will get paid Y. Need lawmakers’ help.</li>
<li>There’s a move towards targeted drug therapies.</li>
<li>New paradigms come with unknown risks.</li>
<li>Market around antibiotics: there’s underlying interest, but some skepticism and fear towards biotech.</li>
<li>There are sub-sections of antibiotics space (e.g. gram positives) that can do well, because of unmet need.</li>
<li>Regulatory: yet, if there’s an unmet need, then we’re behind. Private vs. societal value are not aligned.</li>
<li>Antibiotics: a bit like fire department. We don’t pay fire department by the number of times they put out fires, but as an insurance. Payments are de-linked from the amount of usage.</li>
<li>Private sector model isn’t going to foster investment.</li>
<li>Incentives need to factor in not just pathogens, but also clinical manifestations of the pathogens.</li>
</ul>
<p>Diagnostics?</p>
<ul>
<li>Rapid, within 1-2 hours, which can be good enough to form the basis for decision making, is an unmet need.</li>
<li>Susceptibility testing is also important.</li>
</ul>
<p>Why is there not reduced antibiotic usage in agriculture?</p>
<ul>
<li>Companies that manufacture these products are told to voluntarily remove indications for non-therapeutic uses.</li>
<li>By end of year, antibiotics will need to be prescribed by a vet.</li>
<li>Antibiotics have growth promotion and prophylactic non-therapeutic uses. </li>
<li>Interestingly: high prices per course discourages lax usage. Interesting…… But what if the economic & regulatory model was changed?</li>
</ul>
<p>New antibiotics are a bit like the different types of fire extinguishers (one for petrochemical, one for electrical, etc.). You only buy a new fire extinguisher if it is sufficiently different. New antibiotics have to likewise be sufficiently different.</p>
<p>What’s the one thing that has to be done?</p>
<ul>
<li>From small antibiotic developer’s perspective: prioritization is needed. Favourable reimbursement is needed. Also support the fire department model, but don’t discriminate between large and small developers.</li>
<li>Push incentives are helping, but we need the “pull” incentives, i.e. the known return on investment.</li>
<li>Parallels between rare diseases and antibiotics. "Fire department”-style incentives might be a good way forward.</li>
<li>Rapid, high resolution diagnostics would be really transformative, for example, in their use in clinical trials for rare infections.</li>
<li>Clinical trial networks, infrastructure to be able to study new, narrow-spectrum agents.</li>
</ul>
<p><strong>Session 3: Entrepreneurship</strong></p>
<p>Things to note:</p>
<ul>
<li>Make sure the science is solid. Nature cannot be fooled.<ul>
<li>Regulatory issues must be thought of right from the beginning. </li>
</ul>
</li>
<li>Technology can come from anywhere. A good company is one that addresses an unmet need.</li>
<li>Talk with regulatory people early on. They sometimes have productive things to say as well.</li>
<li>Get a great team together. They should know the market, believe in the mission.</li>
<li>Focus on proof of concept and differentiation. If these are achieved, good things can happen.</li>
<li>Talk with people you trust, who are willing to tell you “this idea is a bad idea”.</li>
</ul>
<p><strong>Session 4: Diagnostics</strong></p>
<ul>
<li>From talking with others over lunch, I found that diagnostics have to be technically so simple (i.e. solid phase chemistry). </li>
<li>Clinical goals:<ul>
<li>Reduce use of antibiotics</li>
<li>Rapid diagnosis and treatment</li>
<li>Data to guide the most appropriate antibiotic</li>
<li>Clinicians need to know when to withhold and when to deploy antibiotics.</li>
</ul>
</li>
<li>Unmet clinical needs:<ul>
<li>Rapid, simple, inexpensive to distinguish viral from bacterial infection, or if a person is even infected or not.<ul>
<li>CLIA-waived - so simple, a non-laboratory person can do it.</li>
<li>Likely a biomarker test.</li>
</ul>
</li>
<li>Rapid, simple inexpensive test to detect viral pathogens<ul>
<li>There are simple molecular assays, but none that are inexpensive.</li>
</ul>
</li>
<li>Rapid identification of bacteria<ul>
<li>Laboratory-based test</li>
<li>Improvements are being made.</li>
</ul>
</li>
<li>Rapid susceptibility testing<ul>
<li>Still a challenge.</li>
</ul>
</li>
</ul>
</li>
<li>Rapid: a context-specific term.<ul>
<li>Bacterial vs. viral: 15-20 minutes.</li>
<li>Viral detection: 15-20 minutes, on-demand and not batched.</li>
<li>Bacterial detection: an hour or less, on-demand.</li>
<li>Susceptibility: \< 6 hours.</li>
</ul>
</li>
<li>Identification of species is better than gram pos/neg.</li>
<li>T2 Biosystems: an interesting platform, PCR-based detection. </li>
<li>Resistance testing: <ul>
<li>Genotypic is helpful for gram-positive strains. Gram-negatives are more challenging.</li>
<li>Phenotypic testing: Accelerate Diagnostics and Geneweave. Accelerate uses FISH and growth characteristics. </li>
</ul>
</li>
<li>How to change a clinician’s practice?<ul>
<li>Reliable test.</li>
<li>Outcomes data - prove to doctor that test makes a difference.</li>
<li>Reimbursement model that encourages use of test.</li>
<li>Educate physicians - what and when to order, how to interpret results. (Interpretation is key!)</li>
</ul>
</li>
<li>T2 diagnostics: magnetic resonance-based detection of pathogens. </li>
<li>What is the best economic model for infectious disease products?</li>
</ul>

  </div>

  <a name="disqus"></a>
  <div class="comments">
<div id="disqus_thread"></div>
<script>
  var disqus_config = function() { this.page.identifier = "/blog/baarn-2016-bullet-point-notes"; this.page.url = "http://www.ericmjl.com/blog/2016/6/16/baarn-2016-bullet-point-notes/"; };
  (function() {
    var d = document, s = d.createElement('script');
    s.src = '//ericmjl.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
  })();
</script>
<noscript>
  Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript"
    rel="nofollow">comments powered by Disqus.</a>
</noscript>
</div>

    </div>

    <nav class="navbar navbar-toggleable navbar-light bg-faded fixed-bottom">
        <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#external-links" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
        </button>
        <div class="collapse navbar-collapse" id="external-links">
            <ul class="navbar-nav mr-auto">
                
                <li class="nav-item">
                    <a class="nav-link" href="https://www.linkedin.com/in/ericmjl"><i class="fa fa-linkedin" aria-hidden="true"></i> LinkedIn</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="http://twitter.com/ericmjl"><i class="fa fa-twitter" aria-hidden="true"></i> Twitter</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="http://github.com/ericmjl"><i class="fa fa-github" aria-hidden="true"></i> GitHub</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="http://stackoverflow.com/users/1274908/ericmjl"><i class="fa fa-stack-overflow" aria-hidden="true"></i> Stack Overflow</a>
                </li>
                
                <li class="nav-item">
                    <a class="nav-link" href="http://shortwhale.com/ericmjl"><i class="fa fa-envelope-o" aria-hidden="true"></i> Contact Me</a>
                </li>
                
            </ul>
        </div>
    </nav>
    <!-- Boostrap JS imports -->
    <script src="https://code.jquery.com/jquery-3.1.1.slim.min.js" integrity="sha384-A7FZj7v+d/sdmMqp/nOQwliLvUsJfDHW+k9Omg/a/EheAdgtzNs3hpfag6Ed950n" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/tether/1.4.0/js/tether.min.js" integrity="sha384-DztdAPBWPRXSA/3eYEEUWrWCy7G5KFbe8fFjk5JAIxUYHKkDx6Qin1DkWx51bBrb" crossorigin="anonymous"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0-alpha.6/js/bootstrap.min.js" integrity="sha384-vBWWzlZJ8ea9aCX4pEW3rVHjgjt7zpkNpZk+02D9phzyeVkE+jo0ieGizqPLForn" crossorigin="anonymous"></script>

</body>
